Grimberg, Dominic CShah, AnkeetInman, Brant A2020-06-012020-06-012019-09-242405-45692405-4569https://hdl.handle.net/10161/20748GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well as muscle-invasive bladder cancer are yielding promising preliminary results.Journal article2020-06-01